INTRODUCTION
Obesity is a common disorder in our country. It is proven predisposing factor of increasing morbidity and mortality in cardiovascular and neurovascular disease. 1, 2 Obesity is a state of excess adipose tissue mass. In presence of nutritional abundance (excess energy intake), sedentary life style and influence importantly by genetic endowment, endocrine and neuronal system increases adipose energy store and produces adverse health consequences. 3 Most widely used method to gauge obesity is Body Mass Index (BMI) which is equal to weight in kilogram divided by height in metre square (Table 1) . 3, 4 Aminotransferases 5, 6 are group of liver enzymes that catalyse inter conversion of amino acid to 2-oxoacid by transfer of aminogroup. These include alanine amino transferase (ALT enzyme commission no-2.6.1.2) and aspartate amino transferase (AST enzyme commission no-2.6.1.1). Gamma glutamyl transferase (GGT enzyme commission no-2.3.2.2) is a peptidase enzyme present in liver, which catalyze hydrolytic cleavage of peptide to form amino acid or small peptides. It catalyzes the transfer of gamma glutamyl moiety of glutathione to acceptor that may be an amino acid. 7 Regional body fat distribution, with abdominal fat accumulation may represent a strong predictor of elevated liver enzymes (ALT, AST & GGT) then relative weight as assessed by BMI. 8, 9 Many studies have found increased levels of ALT, AST & GGT due to alcohol, hypertension and fatty liver. [9] [10] [11] Very less studies have been done in this part of our country to find out direct relation between obesity and levels of liver enzymes. The objective of the study was to find association between levels of liver enzymes in overweight and obese individuals grouped on the basis of BMI cut off.
with ICARE Institute of Medical Sciences and Research. The present study was conducted from Oct 2013 to Jan 2014, after obtaining ethical clearance from the institute. A total of 156 healthy individuals belonging to age group 30 -70 years from both sexes (Males=74 and Females=82), who visited for routine health screening, were selected from Medicine O.P.D. Height and Weight of all the individuals were measured. These healthy individuals were divided into three groups according to their BMI4. Group I -Normal (BMI 18.5 to 24.9), Group II -Overweight (BMI 25.0 to 29.9) and Group III -Obese (BMI >30).
Patients having diabetes, acute or chronic liver disease, renal, cardiovascular or respiratory disease, alcoholics, patients on any medicine which can increase liver enzymes, were not included in study. Serum ALT, AST & GGT enzymes levels of these patients were estimated on Accurex AC 112 plus semi auto analyser from Accurex Biomedical India.
Statistical analysis
Data was analysed by unpaired student t test. Results were expressed as mean ± standard deviation.
RESULTS
In our study the individuals were divided into three groups on the basis of BMI. Total no of individuals in Group I were 72 (38 males & 34 females), in Group II were 39 (17 males & 22 females) and in Group III were 45 (19 males & 26 females). From our study it was seen that the number of females were more as compared to males in Group II and III (Table 2) .
In all the three group values of ALT, AST & GGT were within the normal reference range (Table 3) . However there was an increase trend in the values from normal to obese. No significant relation was found between ALT, AST & GGT and obesity as the p value was > 0.01 when compared between Group II and Group III ( Table 3) .
DISCUSSION
In our present hospital based study we estimated the values of liver enzymes (ALT, AST & GGT) in individuals who were divided into normal, overweight and obese on the basis of BMI. Levels of liver enzymes were not significant statistically when compared between group II and III as the p value was > 0.01.
Rhul CE et al 8 in their study found that the proportion of elevated ALT activity due to overweight and obesity (BMI ≥ 25 kg/m 2 ) was 65%. ALT activity was most strongly associated with higher WHR where as BMI was not independently related. Stranges S et al 9 evaluated the relation between central fat accumulations, as assessed by BMI and liver function tests (ALT, AST & GGT). Abdominal height was consistently a better correlate of ALT & GGT levels than BMI in both sexes. Their findings supported a role for central adiposity independent from BMI in predicting increased levels of hepatic enzymes, likely as a result of unrecognized fatty liver.
Marchesini G et al 12 analysed alanine and aspartate aminotransferases (ALT & AST) and gamma-glutamyl transpeptidase (GGT) in a group of treatment -seeking obese patients. Median ALT & AST increased with increasing obesity class (p = 0.001 and p = 0.005) and exceeded normal limits in 21.0% of cases. Also HOMA-IR increased with the obesity class (p < 0.0001) and was higher in subjects with elevated ALT (p < 0.0001).
In a study done by Strauss RS et al 13 sixty percents of adolescents with elevated ALT levels were either overweight or obese. In addition, approximately 1% obese adolescents demonstrated ALT levels over twice normal. Approximately 50% of obese adolescents who reported modest alcohol ingestion (four times per month or more) had elevated ALT levels. Choi JW 14 found that mean activities (± SD) of serum ALT and 2 ) in man, alanine amino transferase (ALT) was estimated to increase by 18.8 U/L and aspartate amino transferase (AST) increased by 7.1 U/L. In men, interactions between BMI and alcohol consumption were significant (p < 0.001) for ALT& AST, but the degree of effect modification was quantitatively minor. For women relationship of amino transferase levels with BMI did not vary by alcohol consumption.
Adams LA et al 16 in their study found that the majority of the subjects were either overweight (41%) or obese (17%). A minority of subjects were moderate (25%) or heavy drinkers (4%). BMI and waist circumference were strongly associated with ALT and GGT (p<0.0001 for all test). The risk of an elevated ALT was seven fold higher with obesity but only two fold higher with moderate or heavy alcohol use. Obesity accounted for half of all elevated levels in the cohort, where as alcohol excess was responsible for less than 10%.
CONCLUSION
In all the above mentioned studies patients were either alcoholics, smokers, hypertensive or having fatty liver which was the cause of elevated liver enzymes, while in our study no such factor was taken into consideration. This could be one of the causes for normal levels of liver enzymes in the normal, overweight and obese individuals of our study. Till date studies have provided contrast findings. In order to understand complex interaction between liver enzymes and obesity there is a need for study on larger cross section of the population to elucidate the association.
